Company
ChinaGuilin Pharmaceutical Co., Ltd., Guilin, China – FDA Inspections
Inspection records and compliance data for Guilin Pharmaceutical Co., Ltd. in Guilin. 4 FDA inspections on record, 2 Form 483s, last inspected August 18, 2023.
Company Profile
This profile covers Guilin Pharmaceutical Co., Ltd. based in Guilin, China.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 3
- NAI
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected September 2, 2011. Last inspected August 18, 2023.
Most cited issue areas
- Computer control of master formula records1 inspection
- Equipment Design, Size and Location1 inspection
- Procedures not in writing, fully followed1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 18, 2023 | NAI | Human Drugs · Drug Quality Assurance | 1217732 |
| July 19, 2018 | VAI | Human Drugs · Drug Quality Assurance | 1061489 |
| March 13, 2015 | VAI | Human Drugs · Drug Quality Assurance | 920262 |
| September 2, 2011 | VAI | Human Drugs · Drug Quality Assurance | 748950 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- China NMPA · 27 inspections · last December 17, 2019
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Guilin Pharmaceutical Co., Ltd.
FEI Number
3002807125
Address
No. 43 Qilidian Road, Guilin, China
Country
China
ID: 8a53776f-b81a-417d-b1c5-ea1cd2d0b0a8